Portal de Periódicos da CAPES

Autoimmune‐acquired coagulation factor V deficiency with hyperfibrinolytic disseminated intravascular coagulation

2023; Wiley; Volume: 46; Issue: 2 Linguagem: Inglês

10.1111/ijlh.14218

1751-553X

Yuto Kaneda, Kenji Fukuno, Hiroki Minami, Yuri Nonaka, Akiko Horinoue, Yasunori Kuroki, Tsukasa Osaki, Masayoshi Souri, Hidesaku Asakura, Akitada Ichinose,

Hemostasis and retained surgical items

International Journal of Laboratory HematologyEarly View LETTER TO THE EDITOR Autoimmune-acquired coagulation factor V deficiency with hyperfibrinolytic disseminated intravascular coagulation Yuto Kaneda, Corresponding Author Yuto Kaneda [email protected] orcid.org/0009-0005-5910-0609 Department of Hematology, Takayama Red Cross Hospital, Gifu, Japan Correspondence Yuto Kaneda, Department of Hematology, Takayama Red Cross Hospital, 3-11, Tenman-machi, Takayama-shi, Gifu 506-8550, Japan. Email: [email protected]Search for more papers by this authorKenji Fukuno, Kenji Fukuno Department of Hematology, Takayama Red Cross Hospital, Gifu, JapanSearch for more papers by this authorHiroki Minami, Hiroki Minami Inspection Department, Takayama Red Cross Hospital, Gifu, JapanSearch for more papers by this authorYuri Nonaka, Yuri Nonaka Inspection Department, Takayama Red Cross Hospital, Gifu, JapanSearch for more papers by this authorAkiko Horinoue, Akiko Horinoue Inspection Department, Takayama Red Cross Hospital, Gifu, JapanSearch for more papers by this authorYasunori Kuroki, Yasunori Kuroki Inspection Department, Takayama Red Cross Hospital, Gifu, JapanSearch for more papers by this authorTsukasa Osaki, Tsukasa Osaki Yamagata University School of Medicine, Yamagata, Japan The Japanese Collaborative Research Group on Acquired Coagulopathies Supported by the Japanese Ministry of Health, Labor, and Welfare, Yamagata, JapanSearch for more papers by this authorMasayoshi Souri, Masayoshi Souri Yamagata University School of Medicine, Yamagata, Japan The Japanese Collaborative Research Group on Acquired Coagulopathies Supported by the Japanese Ministry of Health, Labor, and Welfare, Yamagata, JapanSearch for more papers by this authorHidesaku Asakura, Hidesaku Asakura The Japanese Collaborative Research Group on Acquired Coagulopathies Supported by the Japanese Ministry of Health, Labor, and Welfare, Yamagata, Japan Department of Hematology, Kanazawa University Hospital, Kanazawa, JapanSearch for more papers by this authorAkitada Ichinose, Akitada Ichinose Yamagata University School of Medicine, Yamagata, Japan The Japanese Collaborative Research Group on Acquired Coagulopathies Supported by the Japanese Ministry of Health, Labor, and Welfare, Yamagata, JapanSearch for more papers by this author Yuto Kaneda, Corresponding Author Yuto Kaneda [email protected] orcid.org/0009-0005-5910-0609 Department of Hematology, Takayama Red Cross Hospital, Gifu, Japan Correspondence Yuto Kaneda, Department of Hematology, Takayama Red Cross Hospital, 3-11, Tenman-machi, Takayama-shi, Gifu 506-8550, Japan. Email: [email protected]Search for more papers by this authorKenji Fukuno, Kenji Fukuno Department of Hematology, Takayama Red Cross Hospital, Gifu, JapanSearch for more papers by this authorHiroki Minami, Hiroki Minami Inspection Department, Takayama Red Cross Hospital, Gifu, JapanSearch for more papers by this authorYuri Nonaka, Yuri Nonaka Inspection Department, Takayama Red Cross Hospital, Gifu, JapanSearch for more papers by this authorAkiko Horinoue, Akiko Horinoue Inspection Department, Takayama Red Cross Hospital, Gifu, JapanSearch for more papers by this authorYasunori Kuroki, Yasunori Kuroki Inspection Department, Takayama Red Cross Hospital, Gifu, JapanSearch for more papers by this authorTsukasa Osaki, Tsukasa Osaki Yamagata University School of Medicine, Yamagata, Japan The Japanese Collaborative Research Group on Acquired Coagulopathies Supported by the Japanese Ministry of Health, Labor, and Welfare, Yamagata, JapanSearch for more papers by this authorMasayoshi Souri, Masayoshi Souri Yamagata University School of Medicine, Yamagata, Japan The Japanese Collaborative Research Group on Acquired Coagulopathies Supported by the Japanese Ministry of Health, Labor, and Welfare, Yamagata, JapanSearch for more papers by this authorHidesaku Asakura, Hidesaku Asakura The Japanese Collaborative Research Group on Acquired Coagulopathies Supported by the Japanese Ministry of Health, Labor, and Welfare, Yamagata, Japan Department of Hematology, Kanazawa University Hospital, Kanazawa, JapanSearch for more papers by this authorAkitada Ichinose, Akitada Ichinose Yamagata University School of Medicine, Yamagata, Japan The Japanese Collaborative Research Group on Acquired Coagulopathies Supported by the Japanese Ministry of Health, Labor, and Welfare, Yamagata, JapanSearch for more papers by this author First published: 19 December 2023 https://doi.org/10.1111/ijlh.14218Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat Open Research DATA AVAILABILITY STATEMENT The datasets generated during the current study are available from the corresponding author upon reasonable request. REFERENCES 1Favaloro EJ, Posen J, Ramakrishna R, et al. Factor V inhibitors: rare or not so uncommon? A multi-laboratory investigation. Blood Coagul Fibrinolysis. 2004; 15: 637-647. 10.1097/00001721-200412000-00003 PubMedWeb of Science®Google Scholar 2Ichinose A, Osaki T, Souri M. A review of coagulation abnormalities of autoimmune acquired factor V deficiency with a focus on Japan. Semin Thromb Hemost. 2022; 48: 206-218. 10.1055/s-0041-1740149 CASPubMedWeb of Science®Google Scholar 3Ang AL, Kuperan P, Ng CH, Ng HJ. Acquired factor V inhibitor. A problem-based systematic review. Thromb Haemost. 2009; 101: 852-859. 10.1160/TH08-11-0767 CASPubMedWeb of Science®Google Scholar 4Cortier D, Van Dreden P, Adam M, Bironien R, François D, Vasse M. Transient factor V deficiency associated with factor V-immunoglobulin complexes but without evidence of a classical inhibitor. Thromb Res. 2016; 147: 10-12. 10.1016/j.thromres.2016.09.013 CASPubMedWeb of Science®Google Scholar 5Osaki T, Souri M, Ogawa Y, Sato H, Mitsui T, Ichinose A. Retrospective examination of coagulation parameters in 33 patients with autoimmune coagulation factor deficiencies in Japan: a single-center analysis. Thromb Res. 2022; 213: 154-162. 10.1016/j.thromres.2022.03.006 CASPubMedWeb of Science®Google Scholar 6Levin MD, Betjes MG, V d Kwast TH, Wenberg BL, Leebeek FW. Acute renal cortex necrosis caused by arterial thrombosis during treatment for acute promyelocytic leukemia. Haematologica. 2003; 88:ECR21. PubMedGoogle Scholar 7Asakura H. Diversity of disseminated intravascular coagulation and selection of appropriate treatments. Int J Hematol. 2021; 113: 10-14. 10.1007/s12185-020-03030-5 CASPubMedWeb of Science®Google Scholar 8Hayashi T, Nakagawa N, Kadohira Y, Morishita E, Asakura H. Rivaroxaban in a patient with disseminated intravascular coagulation associated with an aortic aneurysm: a case report. Ann Intern Med. 2014; 161: 158-159. 10.7326/L14-5014-3 PubMedWeb of Science®Google Scholar 9Ieko M, Ohmura K, Naito S, et al. Measurement of coagulation factor antibody levels is useful for diagnosis and determining therapeutic efficacy in hemorrhagic patients with autoantibodies to coagulation factor VIII and factor V: results from a single center in Japan. Int J Hematol. 2022; 115: 11-20. 10.1007/s12185-021-03212-9 CASPubMedWeb of Science®Google Scholar 10Ogawa H, Souri M, Kanouchi K, et al. A high titer of acquired factor V inhibitor in a hemodialysis patient who developed arterial thrombosis. Int J Hematol. 2019; 109: 214-220. 10.1007/s12185-018-2561-9 CASPubMedWeb of Science®Google Scholar 11De Maertelaere E, Castoldi E, Van Haute I, et al. The interaction of factor V and tissue factor pathway inhibitor in a myeloma patient with acquired factor V deficiency. Haemophilia. 2018; 24: e160-e163. 10.1111/hae.13492 CASPubMedWeb of Science®Google Scholar 12Kadohira Y, Yamada S, Matsuura E, et al. Aortic aneurysm-associated disseminated intravascular coagulation that responded well to a switch from warfarin to rivaroxaban. Intern Med. 2017; 56: 2913-2917. 10.2169/internalmedicine.8666-16 PubMedWeb of Science®Google Scholar Early ViewOnline Version of Record before inclusion in an issue ReferencesRelatedInformation